Home

Palantir Technologies Inc. - Class A Common Stock (PLTR)

158.80
+3.94 (2.54%)
NASDAQ · Last Trade: Jul 27th, 3:22 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close154.86
Open155.63
Bid159.31
Ask159.32
Day's Range155.58 - 160.39
52 Week Range63.40 - 160.39
Volume57,972,347
Market Cap321.96B
PE Ratio (TTM)690.43
EPS (TTM)0.2
Dividend & YieldN/A (N/A)
1 Month Average Volume67,794,539

Chart

About Palantir Technologies Inc. - Class A Common Stock (PLTR)

Palantir Technologies is a public software company that specializes in big data analytics and provides platforms for organizations to integrate, visualize, and analyze large amounts of data from disparate sources. Its flagship products, Palantir Gotham and Palantir Foundry, are designed to assist government agencies and commercial enterprises in making data-driven decisions by offering advanced analytical capabilities, collaborative tools, and visualization features. The company has gained prominence for its work with intelligence and defense organizations, as well as its growing presence in various industries such as finance, healthcare, and manufacturing, enabling clients to derive actionable insights and enhance their operational efficiency. Read More

News & Press Releases

2 High-Flying Artificial Intelligence (AI) Stocks to Sell Before They Plummet 74% and 30%, According to Select Wall Street Analystsfool.com
Not every big AI stock is a buy after the massive bull market run.
Via The Motley Fool · July 26, 2025
After Soaring Nearly 100% So Far This Year, Where Will Palantir Stock Be at the End of 2025?fool.com
Palantir stock continues to crush the broader market, but can the company sustain these gains over the next several months?
Via The Motley Fool · July 26, 2025
Airbnb's Cash Cow Can Thrive Despite Its Challengesfool.com
The short-term rental king is a major player in a trillion-dollar market.
Via The Motley Fool · July 26, 2025
Palantir, Nvidia & Tempus AI Could Be Pharma ETF Darlings That Don't Make Pillsbenzinga.com
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
Via Benzinga · July 26, 2025
Palantir vs. Taiwan Semiconductor Stock: Wall Street Says Buy One and Sell the Otherfool.com
After a strong run-up in both stocks' prices over the last three months, only one remains a buy.
Via The Motley Fool · July 26, 2025
Prediction: President Trump Wants to Fast-Track U.S. Drone Production, but Kratos and AeroVironment Stocks Are the Wrong Way to Play This New Defense Policyfool.com
Beware of investing in "the usual suspects." The Defense Department needs cheaper drones than most U.S. defense contractors are building.
Via The Motley Fool · July 26, 2025
MarketBeat Week in Review – 07/21 - 07/25marketbeat.com
Stocks had another strong week on solid earnings, but tariff and trade policy, along with next week's Fed decision and Jobs report, could stall momentum
Via MarketBeat · July 26, 2025
What's Going on With C3.ai Stock?fool.com
Via The Motley Fool · July 26, 2025
Missed Palantir's Huge 100% Run in 2025? These Stocks Could Be Next.fool.com
Via The Motley Fool · July 26, 2025
Where Will Palantir Technologies Be in 3 Years?fool.com
The standout AI software company has achieved a 1,300% return in just the past 36 months.
Via The Motley Fool · July 26, 2025
Where Will Palantir Stock Be in 5 Years?fool.com
Via The Motley Fool · July 26, 2025
3 Millionaire-Maker Artificial Intelligence (AI) Stocksfool.com
Relying on one stock to make you a millionaire isn't wise, but these three AI stocks have the potential to play a large role in your portfolio's success on that path.
Via The Motley Fool · July 25, 2025
Most active S&P500 stocks in Friday's sessionchartmill.com
Explore the S&P500 index on Friday and find out which stocks are the most active in today's session. Stay updated with the stocks that are capturing market interest and driving market movements.
Via Chartmill · July 25, 2025
How Palantir, Tempus, Nvidia-Backed Recursion Are Disrupting Big Pharmabenzinga.com
AI-native players like Palantir, Tempus, and Recursion are disrupting drug discovery and attracting investors, while Big Pharma struggles.
Via Benzinga · July 25, 2025
Why Palantir Is The 'AI All-Star' You Need To Watchbenzinga.com
Palantir gains spotlight as it eyes a $24B revenue future, fueled by AI momentum, margin strength, and rising defense tech prominence.
Via Benzinga · July 25, 2025
Palantir Technologies Stock Hits A New All-Time High: What's Driving The Action?benzinga.com
Palantir Technologies shares hit a new all-time high Friday morning. Recent momentum has been driven by a string of high-profile government and enterprise developments.
Via Benzinga · July 25, 2025
Looking Into Palantir Technologies's Recent Short Interestbenzinga.com
Via Benzinga · July 25, 2025
This Palantir Technologies Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Fridaybenzinga.com
Via Benzinga · July 25, 2025
Assessing Palantir Technologies: Insights From 12 Financial Analystsbenzinga.com
Via Benzinga · July 25, 2025
5 Tech Stocks That Could Help Set You Up for Lifefool.com
Some of these names are high-risk picks, but the rewards can be generous.
Via The Motley Fool · July 25, 2025
This Dirt Cheap Stock Is Up 262% This Year. Could It Be the Next Palantir?fool.com
Via The Motley Fool · July 25, 2025
Palantir Stock Wins Overweight Rating From Piper Sandler On 'One Of A Kind Growth'investors.com
Piper Sandler initiated Palantir with an overweight rating and 170 price target.
Via Investor's Business Daily · July 25, 2025
Should You Forget Palantir and Buy These 3 Tech Stocks Instead?fool.com
Palantir has been executing incredibly well, but it's overvalued and could be vulnerable to a correction.
Via The Motley Fool · July 25, 2025
Better Artificial Intelligence (AI) Stock: C3.ai vs. Palantirfool.com
These two companies are both leading the artificial intelligence charge, but one business stands out as superior.
Via The Motley Fool · July 25, 2025
Sam Altman Rejects Peter Thiel's 'Dark Lord' Image Amid Palantir Surveillance Report, Warns Against AI Misuse By Governmentbenzinga.com
OpenAI CEO Sam Altman defended Palantir Technologies Inc. co-founder Peter Thiel as "one of the most brilliant people" he knows, pushing back against media characterizations following comments about human survival and recent surveillance allegations.
Via Benzinga · July 25, 2025